Markus Gutsche MD
Critical Care Medicine, Interstitial Lung Diseases, Pleural Disease
Assistant Professor, Division of Pulmonary, Critical Care and Sleep Medicine
Join to View Full Profile
750 East Adams StreetSUNY Upstate Medical University HospitalSyracuse, NY 13210
Phone+1 315-464-4189
Fax+1 315-464-6228
Dr. Gutsche is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2009 - 2012
SUNY Upstate Medical UniversityResidency, Internal Medicine, 2006 - 2009
Albert Ludwigs University Faculty of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2009 - Present
NY State Medical License 2018 - 2027
OH State Medical License 2012 - 2017
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
General Medical Council & Royal College of Physicians (UK)Respiratory Medicine (CESR)
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016
Clinical Trials
- Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31
- A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Oct 13
- Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jul 30
Publications & Presentations
PubMed
- 1 citationsCalcium Channel Blocker-Induced Thrombocytopenia in the Intensive Care Unit: A Rare Presentation and Review of the Literature.Allen Zhou, Michael Sandhu, Brian Min, Gaston Habib, Markus Gutsche
Cureus. 2023-08-01 - 96 citationsConnective Tissue Disease-associated Interstitial Lung Disease: A review.Markus Gutsche, Glenn D. Rosen, Jeffrey J. Swigris
Current Respiratory Care Reports. 2012-09-21 - 4 citationsHemoptysis Due to Breath-Hold Diving Following Chemotherapy and Lung IrradiationMarkus Gutsche, Ware G. Kuschner
Clinical Medicine & Research. 2012-08-01
Journal Articles
- South-West of England’s Experience of the Safety and Tolerability of Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)Barratt SL, Mulholland S, Al Jbour K, Steer H, Gutsche M, Foley N, Srivastava R, Sharp C, Adamali HI, Frontiers in Pharmacology, 12/17/2018
Professional Memberships
- Member
- Member
- Member
- Member
- Royal College of Physicians, London (UK)Associate Member
Other Languages
- German, French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
